AtheroGenics News

For those of you still holding onto AtheroGenics , the research-based pharmaceutical company with two clinical-stage drug development programs , the company has just announced today it has filed for Chapter 11 ...

Drug developer AtheroGenics Inc. said Tuesday it filed for Chapter 11 bankruptcy due to its large debts, which are impairing its ability to develop its lead drug candidate.

AGIX Stock Quote - Atherogenics Inc Stock Quote - AGIX Quote - AGIX Stock Price Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp.

You're at a fruit market. But, instead of just being able to buy apples at this fruit market, you can also sell fruit.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

BUYINS.NET: HTE, TRX, AGIX, OPTR, GLOB, AMPXQ Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days RDATE:29092008 BUYINS.NET, www.buyins.net, announced today that these select companies have ...

AtheroGenics, Inc. , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has restructured its Board of Directors to reduce the number of directors from ...

Financially strapped AtheroGenics Inc. dumped more lousy news on investors. The Alpharetta-based drug-maker, in a regulatory filing, said it has retained Morgan Stanley "to assist it in evaluating restructuring ...

Shares of AtheroGenics Inc. shed 41.5 percent on Tuesday after the company defaulted on $30.5 million worth of convertible notes, a move that may trigger a request for immediate repayment of another $271.9 ...

Penny stocks have huge potential -- that's their blessing and their curse. The potential rewards are enormous.

RDATE:01082008 Our Stocks to Watch tomorrow include Hunt Gold Corp. , B&D Food Corp.

AtheroGenics, Inc. , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced top-line results from its ANDES Phase 3 clinical trial of AGI-1067 for the treatment of ...

Late summer could be make-or-break season for financially hemorrhaging AtheroGenics Inc., at one time one of metro Atlanta's most promising biotech firms.

Main Category: Diabetes Also Included In: Cardiovascular / Cardiology ; Clinical Trials / Drug Trials Article Date: 12 Jun 2008 - 2:00 PDT AtheroGenics, Inc.

Main Category: Diabetes Also Included In: Clinical Trials / Drug Trials ; Cardiovascular / Cardiology Article Date: 26 May 2008 - 12:00 PDT AtheroGenics, Inc.

EWU / EWZ / FXB / FXE / IEV In equity news overnight American Ecology announced a 20% increase to its quarterly dividend, bringing the dividend up to $0.18/share. Bunge announced an 11.8% increase to its ...

The NASDAQ OMX Group, Inc. announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index , which will become effective with the market open on Monday, May 19, 2008. via PrimeNewswire

AtheroGenics, Inc. , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, will be ... via Market Wire

Successful investing requires us to think independently and stick to our convictions. via Fool.com

RDATE:04032008 Orlando, FL -- Stocks gaining traction in yesterday's trading were Diebold, Incorporated, , Converted Organics, Inc., , The Finish Line, Inc., , and AtheroGenics, Inc., . Money flow and a ... via Customer Interaction Solutions